Product Pathways - Cell Cycle / Checkpoint
Phospho-Rpb1 CTD (Ser2/5) Antibody #4735
Applications | Reactivity | Sensitivity | MW (kDa) | Source |
---|---|---|---|---|
W IHC-P | H M R (Sc) (Hm) | Endogenous | 250 | Rabbit |
Applications Key:
W=Western Blotting
IHC-P=Immunohistochemistry (Paraffin)
Reactivity Key:
H=Human
M=Mouse
R=Rat
Sc=S. cerevisiae
Hm=Hamster
Species cross-reactivity is determined by Western blot.
Protocols
- 4735:
- IHC / Paraffin, Western Blotting
Specificity / Sensitivity
Phospho-Rpb1 CTD (Ser2/5) Antibody detects endogenous levels of Rpb1 only when the carboxy-termial domain heptapeptide repeat [Tyr1,Ser2,Pro3,Thr4,Ser5,Pro6,Ser7] is phosphorylated at Ser2/5.
Source / Purification
Polyclonal antibodies are produced by immunizing rabbits with a synthetic phospho-peptide (KLH-coupled) corresponding to residues surrounding Ser2/5 of the Rpb1 CTD heptapeptide. Antibodies are purified by protein A and peptide affinity chromatography.
Western Blotting
Western blot analysis of extracts from MCF-7 cells, untreated or treated with doxorubicin (0.5 μM, 36 h), doxorubicin followed by λ Phosphatase NEB#P0753 (10,000 Units/ml, 1 h), nocodazole (50 ng/ml, 36 h) or nocodazole followed by λ Phosphatase, using Phospho-Rpb1 CTD (Ser2/5) Antibody (upper) or p53 Antibody #9282 (lower).
IHC-P (paraffin)
Immunohistochemical analysis of paraffin-embedded human renal cell carcinoma, untreated (left) or λ phosphatase-treated (right), using Phospho-Rpb1 CTD (Ser2/5) Antibody.
IHC-P (paraffin)
Immunohistochemical analysis of paraffin-embedded human lung carcinoma, showing nuclear localization, using Phospho-Rpb1 CTD (Ser2/5) Antibody.
Background
RNA polymerase II is a complex of 12 proteins that participates in transcription, mRNA processing, and transcription-coupled DNA repair (1,2). The largest subunit, Rpb1, contains a unique heptapeptide: Tyr1, Ser2, Pro3, Thr4, Ser5, Pro6, Ser7, which is repeated up to 52 times in the carboxy-terminal domain (CTD) of Rpb1 (3). This CTD is phosphorylated by cyclin-dependent kinases (CDKs), p44/42 MAPK, DNA-PKcs, and c-Abl (4). DNA damage caused by UV-light, hydrogen peroxide, or cisplatin results in ubiquitination and proteasomal degradation of Rpb1 (1,3). The kinase inhibitor 5,6-dichloro-1-β-D-ribofuranosylbenzimidazole prevents ubiquitination of Rpb1, suggesting that CTD phosphorylation is required for proteolysis (5).
- Svejstrup, J.Q. (2002) Nat. Rev. Mol. Cell. Biol. 3, 21-29.
- Shilatifard, A. et al. (2003) Annu. Rev. Biochem. 72, 693-715.
- Inukai, N. et al. (2004) J. Biol. Chem. 279, 8190-8195.
- Oelgeschlager, T. et al. (2002) J. Cell. Physiol. 190, 160-169.
- Luo, Z. et al. (2001) Mutat. Res. 486, 259-274.
Application References
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
Companion Products
- 3936 Ubiquitin (P4D1) Mouse mAb
- 9101 Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204) Antibody
- 9102 p44/42 MAPK (Erk1/2) Antibody
- 4602 DNA-PK Antibody
- 2916 CDK7 (MO1) Mouse mAb
- 7071 Phototope®-HRP Western Blot Detection System, Anti-rabbit IgG, HRP-linked Antibody
- 7074 Anti-rabbit IgG, HRP-linked Antibody
- 7720 Prestained Protein Marker, Broad Range (Premixed Format)
- 7727 Biotinylated Protein Ladder Detection Pack
- 7003 20X LumiGLO® Reagent and 20X Peroxide
This product is for in vitro research use only and is not intended for use in humans or animals. This product is not intended for use as therapeutic or in diagnostic procedures.